Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity.
Heemskerk N, Gruijs M, Temming AR, Heineke MH, Gout DY, Hellingman T, Tuk CW, Winter PJ, Lissenberg-Thunnissen S, Bentlage AE, de Donatis M, Bögels M, Rösner T, Valerius T, Bakema JE, Vidarsson G, van Egmond M.
Heemskerk N, et al. Among authors: tuk cw.
J Clin Invest. 2021 Mar 15;131(6):e134680. doi: 10.1172/JCI134680.
J Clin Invest. 2021.
PMID: 33561014
Free PMC article.